Cargando…
Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study
BACKGROUND: The traditional anti-inflammation disease-modifying anti-rheumatic drugs (DMARDs) have limited therapeutic effects in rheumatoid arthritis (RA) patients. We previously reported the safety and efficacy of umbilical cord mesenchymal stem cell (UC-MSC) treatment in RA patients that were obs...
Autores principales: | Wang, Liming, Huang, Shigao, Li, Shimei, Li, Ming, Shi, Jun, Bai, Wen, Wang, Qianyun, Zheng, Libo, Liu, Yongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930836/ https://www.ncbi.nlm.nih.gov/pubmed/31908418 http://dx.doi.org/10.2147/DDDT.S225613 |
Ejemplares similares
-
Umbilical Cord Mesenchymal Stem Cell Therapy for Regenerative Treatment of Rheumatoid Arthritis: Opportunities and Challenges
por: Lv, Xiaolan, et al.
Publicado: (2021) -
Cervus and cucumis peptides combined umbilical cord mesenchymal stem cells therapy for rheumatoid arthritis
por: Qi, Tao, et al.
Publicado: (2020) -
Clinical Observation of Employment of Umbilical Cord Derived Mesenchymal Stem Cell for Juvenile Idiopathic Arthritis Therapy
por: Wang, Liming, et al.
Publicado: (2016) -
Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis
por: Liu, Yanying, et al.
Publicado: (2010) -
Intravenous Infusion of Umbilical Cord Blood‐Derived Mesenchymal Stem Cells in Rheumatoid Arthritis: A Phase Ia Clinical Trial
por: Park, Eun Hye, et al.
Publicado: (2018)